News

In an international, controlled clinical trial, subjects with bacterial conjunctivitis (pink-eye) were treated with either AzaSite dosed twice a day for the first two days, followed by once

Under the agreement, IntelliPharmaCeutics will develop the controlled release product, and Par will submit the abbreviated new drug application (ANDA) to the FDA and provide regulatory and legal

The clinical trials will assess ZK-EPO’s safety and efficacy in each of these cancer types. ZK-EPO is the only fully synthetic epothilone in clinical development, and is designed

The new collaboration would have involved the continued provision by Discovery of pharmaceutically relevant chemical compounds and hit follow-up libraries for Pfizer’s exclusive use. At the conclusion of

Under the terms of the agreement, Roche will obtain worldwide rights to BCX-4208 in exchange for a $25 million up-front payment and a $5 million payment as reimbursement

Under the terms of the agreement, PIramed will receive an upfront payment and may receive milestone payments during development and on product approval up to a potential $230

Under the agreement, Affitech receives a license to use Xoma’s bacterial cell expression technology for developing antibody products. Affitech also receives an option for the production of antibodies

The patent office undertook a review of the patent in response to a legal challenge to the crystalline form patent for atorvastatin which expires in 2017. The patent

The FDA has also granted orphan drug designation to SGN-40 for chronic lymphocytic leukemia (CLL) providing Seattle Genetics with seven years of marketing exclusivity in the event of